-
Orphazyme Partnership for ALS Phase 3 Trial of Arimoclomol to Continue for Extension Phase
Orphazyme said its work with Worldwide Clinical Trials will continue through the long-term extension of its ongoing Phase 3 study of oral arimoclomol. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.